AbbVie Loses Monopoly Protection for Humira After Years of Gaming the U.S. Patent System
January 31, 2023 — In response to news that pharmaceutical giant AbbVie is losing its monopoly protection for Humira — a crucial anti-inflammatory treatment and highest-grossing drug in the world — six years after its key patent was supposed to expire, the American Economic Liberties Project released the following statement.
Economic Liberties Launches New Site to Organize Support for FTC’s Proposed Ban on Noncompetes
January 31, 2023 — The American Economic Liberties Project today launched BanNoncompetes.org, a new website that provides a clear and easy way for the millions of workers, small business owners, and entrepreneurs affected by noncompete agreements to voice their support of the Federal Trade Commission’s proposed ban.
NBC Nightly News: Airlines raising requirements for frequent flyer point systems
January 30, 2023 — Economic Liberties' Senior Fellow for Aviation & Travel Bill McGee spoke with NBC Nightly News about frequent flyer programs.
U.S. Court of Appeals Blocks Bad Faith Bankruptcies
January 30, 2023 — In response to news that the Third Circuit rejected Johnson & Johnson’s appeal of a ruling dismissing its subsidiary bankruptcy filing, the American Economic Liberties Project released the following statement.
Washington Post: U.S. to launch talks on partnership with 11 Western Hemisphere nations
January 27, 2023 — Rethink Trade Director Lori Wallach discussed the Biden administration's new approach to trade with Washington Post.